Clinical trial Recruiting at 1 site Interventional Ages 10 to 18

High intensity interval training for pediatric heart transplant recipients

Official title: High Intensity Interval Training in Pediatric Heart Transplant Recipients: Evaluating a Novel Telemedicine Video Game-Linked Exercise Platform (MedBIKE™)

Run by University of Alberta · NCT05451979 · Data updated 2026-11-12

This study is testing a 12-week home workout program to see if it can help kids who have had a heart transplant get stronger and feel better.

Quick facts

Study typeInterventional
Ages10 Years to 18 Years
SexAll
Enrollment10 (estimated)
SponsorUniversity of Alberta
Academic / other
Locations1 site (Edmonton, Alberta)
StatusRecruiting
StartedFebruary 22, 2022
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 13, 2026
Trial IDNCT05451979 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pediatric heart transplant recipients aged 10-18 years who are at least 6 months post-transplant.

Probably not a fit

Patients who may not benefit include those with recent rejection episodes, significant exercise restrictions, or unsuitable home environments for the MedBIKE™ system.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the feasibility of a 12-week home-based high intensity interval training program, MedBIKE™, for pediatric heart transplant recipients. The program will focus on improving exercise capacity, physical activity levels, self-efficacy towards physical activity, and health-related quality of life. The researchers will assess participant enrollment, session compliance, and dropout rates, while monitoring for any adverse events related to the intervention. This is particularly important as there is a significant lack of literature on exercise interventions in this population.

Why it matters

Potential benefit: If successful, this program could enhance the physical fitness and overall quality of life for pediatric heart transplant recipients.

How similar studies have gone: While exercise interventions have shown promise in adult heart transplant recipients, this specific approach using HIIT in pediatric patients is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric heart transplant recipients, at least 6-months post heart transplantation
* Aged 10-18 years

Exclusion Criteria:

* Non-English speaking (thus limiting communication during the MedBIKE™ sessions)
* Home environment cannot accommodate the MedBIKE™ system (for example, space limitations)
* History of multiorgan transplant
* Adult unavailable to supervise the home-based exercise sessions
* Episode of clinical antibody- or cellular-mediated rejection within 3-months of the baseline assessment
* Previous involvement in a cardiac rehabilitation or exercise intervention program
* Primary cardiologist has exercise restricted the participant or counsels against participation
* Previous exercise stress test demonstrating sustained arrhythmias, ST segment elevation or depression greater than 3mm, an inappropriate rise in blood pressure (BP) (\<20 mmHg) or a systolic BP \>200 mmHg, or symptoms of chest pain or syncope
* Resting arterial saturation \<85% or oxygen requirements
* Moderate ventricular systolic dysfunction (or worse) at the most recent echocardiogram
* History of chest pain on exertion
* Unrepaired/unpalliated CHD
* Arrhythmias in the last year (including supraventricular tachycardia, ventricular tachycardia, atrioventricular block (Mobitz II or worse))
* New York Heart Association class II or worse symptoms
* Active medical inter-current illness limiting ability to participate
* Cognitive impairment limiting the communication needed for the HIIT program
* Extracardiac or congenital abnormality limiting the participant's functional ability to exercise

Where it's running

  • University of Alberta
    Edmonton, Alberta, Canada
    Recruiting

Study contacts

  • Principal investigator: Michael Khoury, MD — University of Alberta
  • Study coordinator: Rae Foshaug
  • Email: raef@ualberta.ca
  • Phone: 7804077499

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.